ÂÜÀòÂÒÂ×

Carmen Hurtado de Mendoza Infantes is a seasoned healthcare professional with extensive experience in the pharmaceutical industry, currently serving as Global Disease Lead for Hematology at Alexion Pharmaceuticals since December 2020. Previously, Carmen held various leadership roles, including Head of Commercial at Alexion, Astra Zeneca Rare Disease and Business Lead Acute Care for Spain & Portugal. Carmen's background includes advisory positions at Dialectica and Guidepoint within CNS, Oncology, and Hematology markets. Significant previous roles include Business Unit Director for Oncology at Servier and Teva Pharmaceuticals, where Carmen was responsible for P&L and successful product launches. Carmen's educational qualifications include an Executive MBA from IE Business School and a Master's in Marketing and Business Management from the Canary Islands Business School.